Pages that link to "Q37118177"
Jump to navigation
Jump to search
The following pages link to Reengineering dendritic cell-based anti-cancer vaccines (Q37118177):
Displaying 34 items.
- Dendritic cells derived from pluripotent stem cells: Potential of large scale production (Q26865622) (← links)
- Rationale for a Multimodality Strategy to Enhance the Efficacy of Dendritic Cell-Based Cancer Immunotherapy (Q27686800) (← links)
- The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injury (Q30439547) (← links)
- A dendritic cell vaccine pulsed with autologous hypochlorous acid-oxidized ovarian cancer lysate primes effective broad antitumor immunity: from bench to bedside (Q33724878) (← links)
- Development of automated quantification methodologies of immunohistochemical markers to determine patterns of immune response in breast cancer: a retrospective cohort study (Q34024612) (← links)
- Translating tumor antigens into cancer vaccines (Q34484042) (← links)
- Optimizing dendritic cell-based approaches for cancer immunotherapy (Q34637535) (← links)
- Dendritic cell-based vaccines: barriers and opportunities (Q34661797) (← links)
- A novel DC therapy with manipulation of MKK6 gene on nickel allergy in mice (Q34841315) (← links)
- HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ. (Q35899068) (← links)
- Off-the-shelf Adenoviral-mediated Immunotherapy via Bicistronic Expression of Tumor Antigen and iMyD88/CD40 Adjuvant (Q36085370) (← links)
- A STATus report on DC development (Q36188887) (← links)
- Infected dendritic cells are sufficient to mediate the adjuvant activity generated by Venezuelan equine encephalitis virus replicon particles (Q36458651) (← links)
- Phase I trial of a multi-epitope-pulsed dendritic cell vaccine for patients with newly diagnosed glioblastoma (Q36523499) (← links)
- A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer. (Q36958112) (← links)
- Dendritic cells: a critical player in cancer therapy? (Q37276138) (← links)
- Inhibition of CD4 CD25 regulatory T cell function and conversion into Th1-like effectors by a Toll-like receptor-activated dendritic cell vaccine (Q37297514) (← links)
- Progress in the development of a therapeutic vaccine for breast cancer. (Q37355578) (← links)
- Dendritic cell-based vaccines for the therapy of experimental tumors (Q37773259) (← links)
- Developing an Effective Breast Cancer Vaccine (Q37776145) (← links)
- Guiding the “misguided” – functional conditioning of dendritic cells for the DC‐based immunotherapy against tumours (Q37823518) (← links)
- Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons? (Q37945301) (← links)
- Immunotherapy in pancreatic cancer treatment: a new frontier (Q39175499) (← links)
- Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide (Q39522977) (← links)
- Harnessing dendritic cells to generate cancer vaccines (Q41876317) (← links)
- Enhanced antitumor effects of a dendritic cell vaccine transfected with gastric cancer cell total RNA carrying the 4-1BBL gene in vitro (Q41903166) (← links)
- HER-2/neu tolerant and non-tolerant mice for fine assessment of antimetastatic potency of dendritic cell-tumor cell hybrid vaccines. (Q44294226) (← links)
- Use of antigen-primed dendritic cells for inducing antitumor immune responses in vitro in patients with non-small cell lung cancer (Q49334976) (← links)
- Pleurotus ferulae water extract enhances the maturation and function of murine bone marrow-derived dendritic cells through TLR4 signaling pathway. (Q53591576) (← links)
- Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy (Q61656595) (← links)
- Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results (Q64054796) (← links)
- Effect of cytokine-induced killer cells combined with dendritic cells on the survival rate and expression of 14-3-3ζ and p-Bad proteins in Lewis lung cancer cell lines (Q90221448) (← links)
- Trained Immunity for Personalized Cancer Immunotherapy: Current Knowledge and Future Opportunities (Q93051833) (← links)
- Antitumour dendritic cell vaccination in a priming and boosting approach (Q98237917) (← links)